<

ABSCIENCES (EPA:AB) AB Science announces issuance of a Canadian patent for masitinib in the treatment of ALS with protection until 2037

Transparency directive : regulatory news

01/06/2023 18:01



Other stories

28/04/2024 04:37
28/04/2024 00:41
27/04/2024 17:54
28/04/2024 07:00
27/04/2024 22:39
27/04/2024 20:13
28/04/2024 08:10
28/04/2024 05:10
27/04/2024 20:49
27/04/2024 15:51
28/04/2024 02:40
27/04/2024 16:07
27/04/2024 19:14
28/04/2024 08:19
27/04/2024 18:00
27/04/2024 21:00
27/04/2024 06:00
27/04/2024 21:11
27/04/2024 13:12
27/04/2024 16:36
27/04/2024 08:30
27/04/2024 19:51
28/04/2024 02:27
28/04/2024 03:10
27/04/2024 23:54
27/04/2024 22:19
28/04/2024 06:35
28/04/2024 03:31
28/04/2024 04:00
28/04/2024 02:07
27/04/2024 14:00
26/04/2024 20:00
27/04/2024 20:48
27/04/2024 21:03
27/04/2024 13:26
27/04/2024 17:05
28/04/2024 04:52
26/04/2024 10:51